Salix Pharmaceuticals, Ltd. operates in the Biotechnology & Drugs industry, a subset of the Healthcare sector. The firm has a market capitalization of 2953.48 million, and 490 employees. Currently, 15 Wall Street Analysts cover the firm, including Alpha Street Research. Over the last 52 weeks the shares have returned 30.97%, and has a dividend yield of 0%. View the report to see the AlphaStreetResearch rating for SLXP.
These investment research reports are used by commercial banks, mutual funds, hedge funds and other institutional managers, as well as retail investors and personal financial advisors. These investment research reports contain detailed company analysis using 82 financial, technical and behavioral characteristics to rank each stock relative to all others. The investment research reports cover 3,000 individual companies with latest available data meaning you can compare 185 distinct metrics for your stock against the market average, against the industry and against the individual sector.
Click for Report details:Salix Pharmaceuticals Ltd (SLXP) - Investment Research